Plus: CMS offers medication management educational recording. The clock is ticking when it comes to securing corrections to your new Interim Performance Report under the Expanded Home Health Value-Based Purchasing model. Why it matters: Home health agencies’ VBP scores in 2023 will affect their payments in 2025, to the tune of up to 5 percent positive or negative. The Centers for Medicare & Medicaid Services released HHAs’ first IPR on July 21. The report “provides feedback to HHAs about their measure performance relative to achievement thresholds, benchmarks, improvement thresholds, and the performance of their cohort,” CMS explains in a new IPR Quick Reference Guide. The IPR includes: What it’s not: “HHA performance results shown in the IPR are not used to compute payment adjustments for HHAs competing in the expanded HHVBP Model,” CMS stresses in the guide. “Payment adjustment information will be available in the Annual Performance Report (APR), published annually beginning August 2024,” the agency explains.
The IPR is still important, however, because it gives agencies an idea of how they are competing and where they need to improve. It also gives them a chance to correct any mistakes. But agencies must be quick to do so. “To dispute the calculation of performance measures or interim TPS in the Preliminary IPR, an HHA must submit a recalculation request within 15 calendar days after publication of the Preliminary IPR,” CMS instructs in the guide. “The Final IPR will reflect any changes resulting from an approved recalculation,” trade group LeadingAge explains in a post on its website. HHAs can find their IPRs in their CASPER folders in iQIES, CMS notes. “Find the reports in the ‘HHA Provider Preview Reports’ folder, organized by CCN assigned to an HHA,” LeadingAge explains. “If a HHA has more than one CCN, there will be one IPR per CCN,” it says. And remember, “for the CY 2023 performance year, only active HHAs with CMS Certification Numbers (CCNs) with a Medicare-certification date prior to January 1, 2022, and that meet the minimum data threshold for at least one quality measure, will receive an IPR,” according to the guide. “IPRs are only available to HHAs through iQIES. IPRs are not available to the public,” CMS stresses in an email to providers. This report covers OASIS-based measures drawn from April 2022 to March 2023 and claims-based measures drawn from January to December 2022. Only 2023 data will be used to calculate 2025 payment adjustments. If you missed CMS’ July 27 webinar on the IPR, Overview of the Interim Performance Report (IPR): The July 2023 IPR, you should be able to watch a recording of it when CMS posts it on its VBP webpage in about two weeks, according to the agency. Meanwhile, you can take in a new 30-minute on-demand recording addressing medication management with care transitions. The session aimed at agencies considering “clinical strategies for improvement in the expanded HHVBP Model quality measures” includes “information on evidence-based strategies that can inform Quality Assurance and Performance Improvement (QAPI) plans,” CMS says in a message to providers. Note: The two-page Quick Resource Guide is at https://innovation.cms.gov/media/document/hhvbp-exp-ipr-quick-ref-guide. Links to many VBP materials including the webinar slide deck are on the HHVBP page at https://innovation.cms.gov/innovation-models/expanded-home-health-value-based-purchasing-model. The new medication management on-demand recording is at https://youtu.be/2F98Leg1Qmk.